vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Princeton Bancorp, Inc. (BPRN). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $20.7M, roughly 1.1× Princeton Bancorp, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 3.6%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 9.1%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Princeton Bancorp, Inc. is a U.S.-based bank holding company operating through its community banking subsidiary. It offers retail and commercial banking products including deposit accounts, small business loans, consumer loans, mortgages and wealth management services, primarily serving clients across New Jersey and the U.S. mid-Atlantic region.

ADCT vs BPRN — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.1× larger
ADCT
$23.1M
$20.7M
BPRN
Growing faster (revenue YoY)
ADCT
ADCT
+32.8% gap
ADCT
36.4%
3.6%
BPRN
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
9.1%
BPRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
BPRN
BPRN
Revenue
$23.1M
$20.7M
Net Profit
$6.1M
Gross Margin
Operating Margin
-77.7%
38.2%
Net Margin
29.3%
Revenue YoY
36.4%
3.6%
Net Profit YoY
16.3%
EPS (diluted)
$0.04
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BPRN
BPRN
Q4 25
$23.1M
$20.7M
Q3 25
$15.8M
$21.5M
Q2 25
$18.1M
$21.1M
Q1 25
$17.4M
$20.9M
Q4 24
$16.9M
$20.0M
Q3 24
$18.0M
$19.2M
Q2 24
$17.0M
$18.1M
Q1 24
$17.8M
$17.4M
Net Profit
ADCT
ADCT
BPRN
BPRN
Q4 25
$6.1M
Q3 25
$-41.0M
$6.5M
Q2 25
$-56.6M
$688.0K
Q1 25
$-38.6M
$5.4M
Q4 24
$5.2M
Q3 24
$-44.0M
$-4.5M
Q2 24
$-36.5M
$5.1M
Q1 24
$-46.6M
$4.3M
Operating Margin
ADCT
ADCT
BPRN
BPRN
Q4 25
-77.7%
38.2%
Q3 25
-196.6%
38.5%
Q2 25
-244.1%
2.8%
Q1 25
-163.5%
32.9%
Q4 24
-191.8%
34.0%
Q3 24
-197.4%
-29.1%
Q2 24
-170.5%
34.1%
Q1 24
-188.3%
31.0%
Net Margin
ADCT
ADCT
BPRN
BPRN
Q4 25
29.3%
Q3 25
-260.1%
30.0%
Q2 25
-313.2%
3.3%
Q1 25
-221.8%
25.7%
Q4 24
26.1%
Q3 24
-244.1%
-23.3%
Q2 24
-214.6%
28.4%
Q1 24
-261.1%
24.9%
EPS (diluted)
ADCT
ADCT
BPRN
BPRN
Q4 25
$0.04
$0.89
Q3 25
$-0.30
$0.95
Q2 25
$-0.50
$0.10
Q1 25
$-0.36
$0.77
Q4 24
$-0.26
$0.75
Q3 24
$-0.42
$-0.68
Q2 24
$-0.38
$0.80
Q1 24
$-0.56
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BPRN
BPRN
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$270.7M
Total Assets
$323.1M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BPRN
BPRN
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Q1 24
$234.3M
Total Debt
ADCT
ADCT
BPRN
BPRN
Q4 25
Q3 25
$0
Q2 25
$10.0M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADCT
ADCT
BPRN
BPRN
Q4 25
$-185.8M
$270.7M
Q3 25
$-238.2M
$266.6M
Q2 25
$-199.2M
$261.9M
Q1 25
$-238.2M
$267.0M
Q4 24
$-202.6M
$262.0M
Q3 24
$-171.9M
$261.5M
Q2 24
$-131.7M
$244.8M
Q1 24
$-194.4M
$241.8M
Total Assets
ADCT
ADCT
BPRN
BPRN
Q4 25
$323.1M
$2.3B
Q3 25
$289.8M
$2.2B
Q2 25
$321.6M
$2.2B
Q1 25
$272.5M
$2.3B
Q4 24
$322.0M
$2.3B
Q3 24
$349.1M
$2.4B
Q2 24
$371.8M
$2.0B
Q1 24
$308.0M
$2.0B
Debt / Equity
ADCT
ADCT
BPRN
BPRN
Q4 25
Q3 25
0.00×
Q2 25
0.04×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BPRN
BPRN
Operating Cash FlowLast quarter
$-31.1M
$21.5M
Free Cash FlowOCF − Capex
$20.6M
FCF MarginFCF / Revenue
99.3%
Capex IntensityCapex / Revenue
0.0%
4.3%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$29.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BPRN
BPRN
Q4 25
$-31.1M
$21.5M
Q3 25
$-29.6M
$4.9M
Q2 25
$-24.1M
$3.1M
Q1 25
$-56.3M
$1.3M
Q4 24
$-21.9M
$14.7M
Q3 24
$-25.0M
$1.2M
Q2 24
$-32.8M
$4.3M
Q1 24
$-44.1M
$4.8M
Free Cash Flow
ADCT
ADCT
BPRN
BPRN
Q4 25
$20.6M
Q3 25
$4.7M
Q2 25
$2.9M
Q1 25
$-56.6M
$1.1M
Q4 24
$-21.9M
$13.2M
Q3 24
$-25.3M
$766.0K
Q2 24
$-32.9M
$3.9M
Q1 24
$-44.6M
$4.8M
FCF Margin
ADCT
ADCT
BPRN
BPRN
Q4 25
99.3%
Q3 25
21.6%
Q2 25
13.7%
Q1 25
-325.2%
5.0%
Q4 24
-129.8%
65.9%
Q3 24
-140.2%
4.0%
Q2 24
-193.0%
21.8%
Q1 24
-250.0%
27.3%
Capex Intensity
ADCT
ADCT
BPRN
BPRN
Q4 25
0.0%
4.3%
Q3 25
0.0%
1.1%
Q2 25
0.0%
1.2%
Q1 25
1.5%
1.0%
Q4 24
0.5%
7.6%
Q3 24
1.2%
2.2%
Q2 24
0.2%
2.1%
Q1 24
3.0%
0.4%
Cash Conversion
ADCT
ADCT
BPRN
BPRN
Q4 25
3.54×
Q3 25
0.76×
Q2 25
4.57×
Q1 25
0.23×
Q4 24
2.82×
Q3 24
Q2 24
0.84×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons